127 related articles for article (PubMed ID: 14527511)
1. IL-2 and IL-15 manifest opposing effects on activation of nuclear factor of activated T cells.
Eicher DM
Cell Immunol; 2003 Jun; 223(2):133-42. PubMed ID: 14527511
[TBL] [Abstract][Full Text] [Related]
2. Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154.
Säemann MD; Zeyda M; Diakos C; Szekeres A; Böhmig GA; Kelemen P; Parolini O; Stockinger H; Prieschl EE; Stulnig TM; Baumruker T; Zlabinger GJ
Transplantation; 2003 Jun; 75(11):1864-72. PubMed ID: 12811247
[TBL] [Abstract][Full Text] [Related]
3. IL-15Ralpha is a negative regulator of TCR-activated proliferation in CD4+ T cells.
Lee JM; Chung CY; Chiang WW; Liou YH; Chen CF; Liao NS
J Immunol; 2004 Sep; 173(5):3155-64. PubMed ID: 15322176
[TBL] [Abstract][Full Text] [Related]
4. Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity.
Jan TR; Rao GK; Kaminski NE
Mol Pharmacol; 2002 Feb; 61(2):446-54. PubMed ID: 11809870
[TBL] [Abstract][Full Text] [Related]
5. The basis for TCR-mediated regulation of the IL-2 receptor alpha chain gene: role of widely separated regulatory elements.
Kim HP; Leonard WJ
EMBO J; 2002 Jun; 21(12):3051-9. PubMed ID: 12065418
[TBL] [Abstract][Full Text] [Related]
6. TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.
Tomkowicz B; Walsh E; Cotty A; Verona R; Sabins N; Kaplan F; Santulli-Marotto S; Chin CN; Mooney J; Lingham RB; Naso M; McCabe T
PLoS One; 2015; 10(10):e0140694. PubMed ID: 26492563
[TBL] [Abstract][Full Text] [Related]
7. The interleukin 2 receptor alpha chain/CD25 promoter is a target for nuclear factor of activated T cells.
Schuh K; Twardzik T; Kneitz B; Heyer J; Schimpl A; Serfling E
J Exp Med; 1998 Oct; 188(7):1369-73. PubMed ID: 9763616
[TBL] [Abstract][Full Text] [Related]
8. The IL-15R alpha chain signals through association with Syk in human B cells.
Bulanova E; Budagian V; Pohl T; Krause H; Dürkop H; Paus R; Bulfone-Paus S
J Immunol; 2001 Dec; 167(11):6292-302. PubMed ID: 11714793
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways.
Sancho R; Macho A; de La Vega L; Calzado MA; Fiebich BL; Appendino G; Muñoz E
J Immunol; 2004 Feb; 172(4):2341-51. PubMed ID: 14764703
[TBL] [Abstract][Full Text] [Related]
10. Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site.
Mariner JM; Lantz V; Waldmann TA; Azimi N
J Immunol; 2001 Feb; 166(4):2602-9. PubMed ID: 11160322
[TBL] [Abstract][Full Text] [Related]
11. Local regulation of immune responses: corneal endothelial cells alter t cell activation and cytokine production.
Mi P; Gregerson DS; Kawashima H
Cytokine; 2000 Mar; 12(3):253-64. PubMed ID: 10704253
[TBL] [Abstract][Full Text] [Related]
12. Distinctive signaling pathways through CD82 and beta1 integrins in human T cells.
Iwata S; Kobayashi H; Miyake-Nishijima R; Sasaki T; Souta-Kuribara A; Nori M; Hosono O; Kawasaki H; Tanaka H; Morimoto C
Eur J Immunol; 2002 May; 32(5):1328-37. PubMed ID: 11981820
[TBL] [Abstract][Full Text] [Related]
13. IL-2R alpha on one cell can present IL-2 to IL-2R beta/gamma(c) on another cell to augment IL-2 signaling.
Eicher DM; Waldmann TA
J Immunol; 1998 Nov; 161(10):5430-7. PubMed ID: 9820518
[TBL] [Abstract][Full Text] [Related]
14. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
Tsatsanis C; Patriotis C; Tsichlis PN
Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
[TBL] [Abstract][Full Text] [Related]
15. SOCS-1 can suppress CD3zeta- and Syk-mediated NF-AT activation in a non-lymphoid cell line.
Matsuda T; Yamamoto T; Kishi H; Yoshimura A; Muraguchi A
FEBS Lett; 2000 Apr; 472(2-3):235-40. PubMed ID: 10788618
[TBL] [Abstract][Full Text] [Related]
16. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
Schnaider T; Somogyi J; Csermely P; Szamel M
Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
[TBL] [Abstract][Full Text] [Related]
17. miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation.
Xue F; Li H; Zhang J; Lu J; Xia Y; Xia Q
Genes Immun; 2013 Mar; 14(2):127-31. PubMed ID: 23303246
[TBL] [Abstract][Full Text] [Related]
18. Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes.
Shatrova AN; Mityushova EV; Vassilieva IO; Aksenov ND; Zenin VV; Nikolsky NN; Marakhova II
PLoS One; 2016; 11(12):e0167215. PubMed ID: 27936140
[TBL] [Abstract][Full Text] [Related]
19. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses.
Bennett F; Luxenberg D; Ling V; Wang IM; Marquette K; Lowe D; Khan N; Veldman G; Jacobs KA; Valge-Archer VE; Collins M; Carreno BM
J Immunol; 2003 Jan; 170(2):711-8. PubMed ID: 12517932
[TBL] [Abstract][Full Text] [Related]
20. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors.
Márquez N; Sancho R; Macho A; Calzado MA; Fiebich BL; Muñoz E
J Pharmacol Exp Ther; 2004 Mar; 308(3):993-1001. PubMed ID: 14617683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
